A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy Adults

NCT01078376 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

29

Enrollment

INDUSTRY

Sponsor class

Stopped Business Decision (see below)

Conditions

Hypertension

Interventions

DRUG: Azilsartan medoxomil (TAK-491)
DRUG: Azilsartan medoxomil (TAK-491)
DRUG: Azilsartan medoxomil (TAK-491)
DRUG: Azilsartan medoxomil (TAK-491)

Sponsor

Takeda